⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPRX News
Kiora Pharmaceuticals, Inc. Common Stock
Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders
prnewswire.com
KPRX